5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

 

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
W

New RT Approaches to Stage III NSCLC Pts: Can Radiotherapy Be Further Improved? & Ultra-High Dose Rate Radiation

By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Wally Curran
By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Wally Curran
99 views
March 12, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Lung Cancers
09:53
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

2L Options for EGFR+ NSCLC: How to Treat Osimertinib Resistance? Wha…

Feat. S. Kazmi
15:37
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Update on Early Stage NSCLC: Role of Screening, Neoadjuvant Therapie…

Feat. J. Porter
10:32
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Use of Stereotactic Radiation for NSCLC Pts & Vale of IO after S…

Feat. W. Curran
09:04
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

New RT Approaches to Stage III NSCLC Pts: Can Radiotherapy Be Furthe…

Feat. W. Curran
10:53
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

2020 Update on NSCLC Targeted Therapies: ALK, ROS1, RET, MET, NTRK, …

Feat. S. Kazmi
14:33
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Immunotherapy in NSCLC: Progression, irAE management & Combinati…

Feat. R. Salgia